Antitumor efficacy of extracellular complexes with gadolinium in Binary Radiotherapy

Area of Science:

• Oncology
• Radiotherapy
• Pharmacology

Background:

• Binary Radiotherapy (BRT) is an emerging treatment modality.
• Gadolinium-based contrast agents are being explored for therapeutic applications.
• Extracellular Gd-DTPA's role in BRT requires further investigation.

Purpose of the Study:

• To evaluate the efficacy of extracellular gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) in Binary Radiotherapy.
• To assess the impact of Gd-DTPA combined with X-ray irradiation on tumor growth in a preclinical model.

Main Methods:

• The study utilized a transplantable adenocarcinoma Ca755 model in mice.
• Contrast-enhanced radiotherapy, a form of BRT, was employed.
• Mice received intravenous Gd-DTPA followed by 10 Gy X-irradiation.

Main Results:

• Intravenous administration of 0.3 ml of 0.5 M Gd-DTPA solution followed by 10 Gy X-irradiation resulted in a T/C% of 10±3%.
• Complete tumor regression was observed in 25% of the treated mice.
• Gd-DTPA demonstrated radiosensitizing effects in this experimental setup.

Conclusions:

• Extracellular Gd-DTPA can enhance the efficacy of X-ray based Binary Radiotherapy.
• This combination therapy shows promise for cancer treatment, warranting further clinical investigation.
• Gd-DTPA represents a potential radiosensitizer for oncological applications.